

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to parathyroid hormone (GO:0071107) | 9.77905925 |
| 2 | renal absorption (GO:0070293) | 8.98694206 |
| 3 | * excretion (GO:0007588) | 8.91400896 |
| 4 | lysine metabolic process (GO:0006553) | 8.66794991 |
| 5 | lysine catabolic process (GO:0006554) | 8.66794991 |
| 6 | drug transmembrane transport (GO:0006855) | 8.07392751 |
| 7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.04861752 |
| 8 | urate metabolic process (GO:0046415) | 7.94204788 |
| 9 | metanephric nephron tubule development (GO:0072234) | 7.80037244 |
| 10 | metanephric tubule development (GO:0072170) | 7.80037244 |
| 11 | response to lead ion (GO:0010288) | 7.28791499 |
| 12 | organic cation transport (GO:0015695) | 7.28219240 |
| 13 | metanephric nephron epithelium development (GO:0072243) | 7.15523892 |
| 14 | positive regulation of catenin import into nucleus (GO:0035413) | 7.08627457 |
| 15 | drug transport (GO:0015893) | 6.99452285 |
| 16 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 6.87478838 |
| 17 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 6.76838976 |
| 18 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 6.73674584 |
| 19 | phosphate ion transport (GO:0006817) | 6.63982967 |
| 20 | metanephric epithelium development (GO:0072207) | 6.57977830 |
| 21 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 6.28967556 |
| 22 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 6.22476435 |
| 23 | negative regulation of sterol transport (GO:0032372) | 6.18771341 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 6.18771341 |
| 25 | negative regulation of metanephros development (GO:0072217) | 6.10409291 |
| 26 | response to thyroid hormone (GO:0097066) | 6.05537864 |
| 27 | nephron tubule formation (GO:0072079) | 5.99673472 |
| 28 | aspartate family amino acid catabolic process (GO:0009068) | 5.98636059 |
| 29 | glyoxylate metabolic process (GO:0046487) | 5.93100483 |
| 30 | quaternary ammonium group transport (GO:0015697) | 5.84860459 |
| 31 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.80706231 |
| 32 | cysteine metabolic process (GO:0006534) | 5.75347134 |
| 33 | sodium-independent organic anion transport (GO:0043252) | 5.70704920 |
| 34 | one-carbon compound transport (GO:0019755) | 5.66588398 |
| 35 | response to magnesium ion (GO:0032026) | 5.65186131 |
| 36 | tricarboxylic acid metabolic process (GO:0072350) | 5.63892552 |
| 37 | nephron tubule development (GO:0072080) | 5.60906032 |
| 38 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.59325150 |
| 39 | phosphate ion transmembrane transport (GO:0035435) | 5.51812866 |
| 40 | * response to mercury ion (GO:0046689) | 5.45855885 |
| 41 | 2-oxoglutarate metabolic process (GO:0006103) | 5.41238680 |
| 42 | inositol metabolic process (GO:0006020) | 5.26711771 |
| 43 | branched-chain amino acid metabolic process (GO:0009081) | 5.09717408 |
| 44 | short-chain fatty acid metabolic process (GO:0046459) | 5.06322351 |
| 45 | valine metabolic process (GO:0006573) | 5.04800176 |
| 46 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 5.03562468 |
| 47 | renal tubule development (GO:0061326) | 4.97965658 |
| 48 | response to vitamin A (GO:0033189) | 4.92271388 |
| 49 | pattern specification involved in kidney development (GO:0061004) | 4.90728174 |
| 50 | bone remodeling (GO:0046849) | 4.85414632 |
| 51 | cellular response to ammonium ion (GO:0071242) | 4.82954165 |
| 52 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.80327178 |
| 53 | regulation of protein localization to cell surface (GO:2000008) | 4.71432904 |
| 54 | vitamin D metabolic process (GO:0042359) | 4.69998416 |
| 55 | * polyol transport (GO:0015791) | 4.69702591 |
| 56 | homocysteine metabolic process (GO:0050667) | 4.68841842 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 4.67929744 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 4.67929744 |
| 59 | tryptophan catabolic process (GO:0006569) | 4.67929744 |
| 60 | amino-acid betaine transport (GO:0015838) | 4.65852417 |
| 61 | carnitine transport (GO:0015879) | 4.65852417 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 4.60839093 |
| 63 | nephron epithelium development (GO:0072009) | 4.59464901 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.55140737 |
| 65 | L-phenylalanine metabolic process (GO:0006558) | 4.55140737 |
| 66 | mammary gland alveolus development (GO:0060749) | 4.52483664 |
| 67 | branched-chain amino acid catabolic process (GO:0009083) | 4.46020355 |
| 68 | tryptophan metabolic process (GO:0006568) | 4.38677750 |
| 69 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.35422627 |
| 70 | L-phenylalanine catabolic process (GO:0006559) | 4.35422627 |
| 71 | kynurenine metabolic process (GO:0070189) | 4.35327024 |
| 72 | ERK1 and ERK2 cascade (GO:0070371) | 4.32740356 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 4.31427336 |
| 74 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 4.29484258 |
| 75 | glutathione biosynthetic process (GO:0006750) | 4.29312145 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 4.27882652 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 4.25774717 |
| 78 | regulation of fever generation (GO:0031620) | 4.22170820 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 4.21518811 |
| 80 | glomerular visceral epithelial cell development (GO:0072015) | 4.20782766 |
| 81 | NADH metabolic process (GO:0006734) | 4.17994502 |
| 82 | modified amino acid transport (GO:0072337) | 4.16168074 |
| 83 | phosphate ion homeostasis (GO:0055062) | 4.13439780 |
| 84 | trivalent inorganic anion homeostasis (GO:0072506) | 4.13439780 |
| 85 | toxin transport (GO:1901998) | 4.12944138 |
| 86 | positive regulation of heat generation (GO:0031652) | 4.11983739 |
| 87 | glutamate metabolic process (GO:0006536) | 4.11808895 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 4.10262135 |
| 89 | proline metabolic process (GO:0006560) | 4.08086491 |
| 90 | carnitine metabolic process (GO:0009437) | 4.01583916 |
| 91 | drug catabolic process (GO:0042737) | 4.00643789 |
| 92 | urogenital system development (GO:0001655) | 4.00441877 |
| 93 | fatty acid oxidation (GO:0019395) | 3.98750295 |
| 94 | cell differentiation involved in metanephros development (GO:0072202) | 3.96771206 |
| 95 | tricarboxylic acid cycle (GO:0006099) | 3.96752072 |
| 96 | fructose metabolic process (GO:0006000) | 3.95277813 |
| 97 | serine family amino acid catabolic process (GO:0009071) | 3.93846969 |
| 98 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.92871982 |
| 99 | lipid oxidation (GO:0034440) | 3.91529986 |
| 100 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.84304091 |
| 101 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.84179581 |
| 102 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.83302880 |
| 103 | mesonephros development (GO:0001823) | 3.81923401 |
| 104 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.78188550 |
| 105 | beta-amyloid metabolic process (GO:0050435) | 3.77868663 |
| 106 | nephron tubule morphogenesis (GO:0072078) | 3.74346481 |
| 107 | nephron epithelium morphogenesis (GO:0072088) | 3.74346481 |
| 108 | amino acid salvage (GO:0043102) | 3.74159571 |
| 109 | L-methionine salvage (GO:0071267) | 3.74159571 |
| 110 | L-methionine biosynthetic process (GO:0071265) | 3.74159571 |
| 111 | cardiovascular system development (GO:0072358) | 3.72854355 |
| 112 | serine family amino acid metabolic process (GO:0009069) | 3.72139425 |
| 113 | regulation of cholesterol efflux (GO:0010874) | 3.72098653 |
| 114 | S-adenosylmethionine metabolic process (GO:0046500) | 3.70266956 |
| 115 | glomerular epithelial cell development (GO:0072310) | 3.69867899 |
| 116 | ketone body metabolic process (GO:1902224) | 3.69801855 |
| 117 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.63444729 |
| 118 | transepithelial transport (GO:0070633) | 3.62009117 |
| 119 | oxaloacetate metabolic process (GO:0006107) | 3.59781195 |
| 120 | exogenous drug catabolic process (GO:0042738) | 3.59361471 |
| 121 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.57330634 |
| 122 | glycoside metabolic process (GO:0016137) | 3.55582297 |
| 123 | response to phenylpropanoid (GO:0080184) | 3.53588747 |
| 124 | fatty acid catabolic process (GO:0009062) | 3.52233666 |
| 125 | hyperosmotic salinity response (GO:0042538) | 3.50980667 |
| 126 | regulation of catenin import into nucleus (GO:0035412) | 3.50137162 |
| 127 | cellular amino acid catabolic process (GO:0009063) | 3.50057534 |
| 128 | sodium ion transport (GO:0006814) | 3.48909983 |
| 129 | peptide biosynthetic process (GO:0043043) | 3.44866300 |
| 130 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.42992245 |
| 131 | regulation of stem cell maintenance (GO:2000036) | 3.42284769 |
| 132 | regulation of anion transport (GO:0044070) | 3.41163424 |
| 133 | biotin metabolic process (GO:0006768) | 3.40681142 |
| 134 | negative regulation of kidney development (GO:0090185) | 3.40022681 |
| 135 | alpha-amino acid catabolic process (GO:1901606) | 3.39212863 |
| 136 | aromatic amino acid family metabolic process (GO:0009072) | 3.39053884 |
| 137 | succinate metabolic process (GO:0006105) | 3.37946853 |
| 138 | sulfur amino acid catabolic process (GO:0000098) | 3.35397119 |
| 139 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.33559882 |
| 140 | vitamin transport (GO:0051180) | 3.33167459 |
| 141 | regulation of heat generation (GO:0031650) | 3.32418012 |
| 142 | positive regulation of digestive system process (GO:0060456) | 3.31615114 |
| 143 | inorganic anion transport (GO:0015698) | 3.28280944 |
| 144 | indole-containing compound metabolic process (GO:0042430) | 3.27611787 |
| 145 | kidney epithelium development (GO:0072073) | 3.27495824 |
| 146 | monocarboxylic acid catabolic process (GO:0072329) | 3.26746250 |
| 147 | * renal system process (GO:0003014) | 3.25824766 |
| 148 | sodium ion export (GO:0071436) | 3.21885588 |
| 149 | indolalkylamine metabolic process (GO:0006586) | 3.21878451 |
| 150 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.21873459 |
| 151 | organic acid catabolic process (GO:0016054) | 3.21706103 |
| 152 | carboxylic acid catabolic process (GO:0046395) | 3.21706103 |
| 153 | positive regulation of metanephros development (GO:0072216) | 3.21561244 |
| 154 | response to growth hormone (GO:0060416) | 3.20927412 |
| 155 | chloride transmembrane transport (GO:1902476) | 3.20860949 |
| 156 | glutathione derivative biosynthetic process (GO:1901687) | 3.20147995 |
| 157 | glutathione derivative metabolic process (GO:1901685) | 3.20147995 |
| 158 | mesenchymal to epithelial transition (GO:0060231) | 3.19456259 |
| 159 | peptide catabolic process (GO:0043171) | 3.17692149 |
| 160 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.08949174 |
| 161 | inorganic anion transmembrane transport (GO:0098661) | 3.08875920 |
| 162 | regulation of calcium ion import (GO:0090279) | 3.07790261 |
| 163 | glycine metabolic process (GO:0006544) | 3.05745363 |
| 164 | negative regulation of lipid transport (GO:0032369) | 3.04945924 |
| 165 | sodium ion homeostasis (GO:0055078) | 3.03721849 |
| 166 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.03298135 |
| 167 | metanephric mesenchyme development (GO:0072075) | 3.01505607 |
| 168 | specification of organ identity (GO:0010092) | 3.01091631 |
| 169 | kidney development (GO:0001822) | 2.96972323 |
| 170 | chloride transport (GO:0006821) | 2.96882099 |
| 171 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.91503360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.65585806 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84078428 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.59193970 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.75073696 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.46409340 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.28517963 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.95256394 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.93294634 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.89445685 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.74711202 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.59312153 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56616262 |
| 13 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.50736169 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.49524816 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.41369452 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34535667 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17502237 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.04758317 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.92716473 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89158079 |
| 21 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.85904043 |
| 22 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.85030453 |
| 23 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.81420806 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.80981088 |
| 25 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.80867345 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73103997 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.72577925 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68366818 |
| 29 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.67227052 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61836845 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61497574 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59728595 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59194601 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55271559 |
| 35 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.53417659 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51808036 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51328816 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50375584 |
| 39 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50202593 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46883758 |
| 41 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.45581495 |
| 42 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.39059289 |
| 43 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.38623709 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38033755 |
| 45 | CBP_21632823_ChIP-Seq_H3396_Human | 1.37131320 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.32889556 |
| 47 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31706255 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.30416006 |
| 49 | RXR_22108803_ChIP-Seq_LS180_Human | 1.29065774 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29005470 |
| 51 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28008108 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26274783 |
| 53 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25891967 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25791597 |
| 55 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.25779366 |
| 56 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.25457982 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24198828 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23930887 |
| 59 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23821698 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23694023 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23681696 |
| 62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23599232 |
| 63 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.23406104 |
| 64 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23279156 |
| 65 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23279156 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22560334 |
| 67 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21744303 |
| 68 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20401218 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20049134 |
| 70 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19533310 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19396843 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19294328 |
| 73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19227983 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.19158056 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.19158056 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18847701 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18290683 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17190989 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16881538 |
| 80 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16134173 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15949922 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15920875 |
| 83 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15357017 |
| 84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15131991 |
| 85 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.13852407 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13672518 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12956312 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12950823 |
| 89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12369728 |
| 90 | TBL1_22424771_ChIP-Seq_293T_Human | 1.12061443 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10686376 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10338094 |
| 93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10222847 |
| 94 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10048216 |
| 95 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10026893 |
| 96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09294374 |
| 97 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.08891511 |
| 98 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.08538182 |
| 99 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08491335 |
| 100 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08296968 |
| 101 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.08051355 |
| 102 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.07956425 |
| 103 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.07299972 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07020829 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06454286 |
| 106 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06410265 |
| 107 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.06381197 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05590717 |
| 109 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.05526812 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05464619 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05256337 |
| 112 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.04758959 |
| 113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03413971 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02687360 |
| 115 | NFYA_21822215_ChIP-Seq_K562_Human | 1.01802630 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01343758 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01324540 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01193372 |
| 119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01003805 |
| 120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00795090 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99357563 |
| 122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99256929 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99132908 |
| 124 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98809899 |
| 125 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96903703 |
| 126 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96816949 |
| 127 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95204374 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93150916 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92337123 |
| 130 | * SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.91748952 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90653684 |
| 132 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90551240 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90542264 |
| 134 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.88521046 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88295499 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88076795 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86204450 |
| 138 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86138754 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85825283 |
| 140 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85445555 |
| 141 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.84513075 |
| 142 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84202757 |
| 143 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82250869 |
| 144 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81274242 |
| 145 | P68_20966046_ChIP-Seq_HELA_Human | 0.81137375 |
| 146 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80960453 |
| 147 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.80910633 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80876483 |
| 149 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80816886 |
| 150 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80807895 |
| 151 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80505542 |
| 152 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80442331 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77766737 |
| 154 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.77589121 |
| 155 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.77589057 |
| 156 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76869706 |
| 157 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75817390 |
| 158 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75392335 |
| 159 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74766327 |
| 160 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74089154 |
| 161 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.74052382 |
| 162 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74050589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 9.20174124 |
| 2 | MP0003195_calcinosis | 7.14055226 |
| 3 | MP0005360_urolithiasis | 6.10658873 |
| 4 | * MP0001756_abnormal_urination | 4.62099959 |
| 5 | MP0005332_abnormal_amino_acid | 4.46594035 |
| 6 | MP0001765_abnormal_ion_homeostasis | 4.04098438 |
| 7 | * MP0009643_abnormal_urine_homeostasis | 3.96725714 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.80923910 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.45342945 |
| 10 | MP0005636_abnormal_mineral_homeostasis | 3.19195439 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.19130953 |
| 12 | * MP0002136_abnormal_kidney_physiology | 3.06514329 |
| 13 | MP0004885_abnormal_endolymph | 2.43985146 |
| 14 | MP0003878_abnormal_ear_physiology | 2.19366202 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.19366202 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.18166059 |
| 17 | MP0003252_abnormal_bile_duct | 2.14876901 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06151982 |
| 19 | MP0001958_emphysema | 1.96763543 |
| 20 | MP0005365_abnormal_bile_salt | 1.70039218 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.63697344 |
| 22 | MP0002168_other_aberrant_phenotype | 1.62392908 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.59685943 |
| 24 | MP0005451_abnormal_body_composition | 1.56599531 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49826113 |
| 26 | MP0000230_abnormal_systemic_arterial | 1.38970122 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.35609394 |
| 28 | MP0003283_abnormal_digestive_organ | 1.28875935 |
| 29 | MP0003186_abnormal_redox_activity | 1.26148846 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.20854072 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.15328025 |
| 32 | MP0003045_fibrosis | 1.14216381 |
| 33 | * MP0002135_abnormal_kidney_morphology | 1.13770804 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.13119182 |
| 35 | MP0002928_abnormal_bile_duct | 1.06606654 |
| 36 | MP0005535_abnormal_body_temperature | 1.06592142 |
| 37 | MP0001764_abnormal_homeostasis | 1.00353923 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 0.99404385 |
| 39 | MP0002876_abnormal_thyroid_physiology | 0.98661067 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 0.93225548 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 0.89405090 |
| 42 | MP0005666_abnormal_adipose_tissue | 0.88726489 |
| 43 | MP0009672_abnormal_birth_weight | 0.87479238 |
| 44 | MP0005395_other_phenotype | 0.84654506 |
| 45 | MP0003959_abnormal_lean_body | 0.81345498 |
| 46 | MP0003646_muscle_fatigue | 0.79956922 |
| 47 | MP0008004_abnormal_stomach_pH | 0.77616376 |
| 48 | MP0004742_abnormal_vestibular_system | 0.77048772 |
| 49 | MP0005670_abnormal_white_adipose | 0.75959383 |
| 50 | MP0003638_abnormal_response/metabolism_ | 0.74918442 |
| 51 | MP0002896_abnormal_bone_mineralization | 0.74087616 |
| 52 | * MP0000538_abnormal_urinary_bladder | 0.73038794 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 0.71038987 |
| 54 | MP0001666_abnormal_nutrient_absorption | 0.70719179 |
| 55 | MP0003183_abnormal_peptide_metabolism | 0.69208985 |
| 56 | * MP0009642_abnormal_blood_homeostasis | 0.65985139 |
| 57 | * MP0001270_distended_abdomen | 0.65942825 |
| 58 | MP0004264_abnormal_extraembryonic_tissu | 0.63945124 |
| 59 | MP0002796_impaired_skin_barrier | 0.63923870 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 0.62240068 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.61499312 |
| 62 | MP0004272_abnormal_basement_membrane | 0.60604672 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.60288891 |
| 64 | MP0003943_abnormal_hepatobiliary_system | 0.59123497 |
| 65 | MP0003315_abnormal_perineum_morphology | 0.56958239 |
| 66 | MP0005165_increased_susceptibility_to | 0.55457601 |
| 67 | MP0001661_extended_life_span | 0.55068679 |
| 68 | MP0003938_abnormal_ear_development | 0.54183536 |
| 69 | MP0009764_decreased_sensitivity_to | 0.52776047 |
| 70 | MP0003329_amyloid_beta_deposits | 0.51241877 |
| 71 | MP0004147_increased_porphyrin_level | 0.49590739 |
| 72 | MP0000747_muscle_weakness | 0.49375690 |
| 73 | MP0003075_altered_response_to | 0.47899290 |
| 74 | * MP0002069_abnormal_eating/drinking_beha | 0.47481570 |
| 75 | MP0002971_abnormal_brown_adipose | 0.47209892 |
| 76 | MP0000609_abnormal_liver_physiology | 0.46975964 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.46973871 |
| 78 | MP0002234_abnormal_pharynx_morphology | 0.46565900 |
| 79 | MP0004858_abnormal_nervous_system | 0.46248466 |
| 80 | MP0003795_abnormal_bone_structure | 0.45840912 |
| 81 | MP0010329_abnormal_lipoprotein_level | 0.45763487 |
| 82 | MP0000751_myopathy | 0.44682018 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.41823919 |
| 84 | MP0008469_abnormal_protein_level | 0.40898889 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.39739311 |
| 86 | MP0009703_decreased_birth_body | 0.38790130 |
| 87 | MP0005501_abnormal_skin_physiology | 0.38532126 |
| 88 | MP0003953_abnormal_hormone_level | 0.37991356 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.37880761 |
| 90 | MP0004233_abnormal_muscle_weight | 0.37573596 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.37286175 |
| 92 | MP0004484_altered_response_of | 0.36386310 |
| 93 | MP0000026_abnormal_inner_ear | 0.34846085 |
| 94 | MP0001177_atelectasis | 0.34838321 |
| 95 | MP0003879_abnormal_hair_cell | 0.34741672 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.34686863 |
| 97 | MP0001944_abnormal_pancreas_morphology | 0.34543210 |
| 98 | MP0002972_abnormal_cardiac_muscle | 0.34412914 |
| 99 | MP0002098_abnormal_vibrissa_morphology | 0.33746917 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.32996292 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 0.32350525 |
| 102 | MP0003011_delayed_dark_adaptation | 0.32254597 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.31847516 |
| 104 | MP0001963_abnormal_hearing_physiology | 0.31755387 |
| 105 | MP0000598_abnormal_liver_morphology | 0.31667122 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.31082028 |
| 107 | MP0001191_abnormal_skin_condition | 0.30756671 |
| 108 | MP0001664_abnormal_digestion | 0.30606793 |
| 109 | MP0002115_abnormal_skeleton_extremities | 0.30562245 |
| 110 | MP0003941_abnormal_skin_development | 0.30387893 |
| 111 | MP0008872_abnormal_physiological_respon | 0.30283379 |
| 112 | MP0002108_abnormal_muscle_morphology | 0.29475925 |
| 113 | MP0008775_abnormal_heart_ventricle | 0.29151961 |
| 114 | MP0005330_cardiomyopathy | 0.28698519 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.28410007 |
| 116 | MP0000371_diluted_coat_color | 0.27991819 |
| 117 | * MP0001731_abnormal_postnatal_growth | 0.27742352 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.25546262 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.24086610 |
| 120 | MP0000163_abnormal_cartilage_morphology | 0.21157068 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.20650257 |
| 122 | MP0000566_synostosis | 0.18568410 |
| 123 | * MP0000534_abnormal_ureter_morphology | 0.18233965 |
| 124 | MP0003942_abnormal_urinary_system | 0.16974120 |
| 125 | MP0005452_abnormal_adipose_tissue | 0.15934872 |
| 126 | MP0008874_decreased_physiological_sensi | 0.15304620 |
| 127 | * MP0002082_postnatal_lethality | 0.14260758 |
| 128 | * MP0010770_preweaning_lethality | 0.14260758 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.13020761 |
| 130 | MP0000762_abnormal_tongue_morphology | 0.12997670 |
| 131 | * MP0010769_abnormal_survival | 0.10111106 |
| 132 | MP0005409_darkened_coat_color | 0.09364067 |
| 133 | MP0009780_abnormal_chondrocyte_physiolo | 0.09237741 |
| 134 | * MP0010768_mortality/aging | 0.08375874 |
| 135 | MP0000049_abnormal_middle_ear | 0.08307645 |
| 136 | MP0002638_abnormal_pupillary_reflex | 0.08265590 |
| 137 | MP0002113_abnormal_skeleton_development | 0.07927963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 9.19578591 |
| 2 | Abnormality of chloride homeostasis (HP:0011422) | 8.86191495 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 8.82455699 |
| 4 | Hypomagnesemia (HP:0002917) | 8.48878792 |
| 5 | * Polyuria (HP:0000103) | 7.75827388 |
| 6 | Renal salt wasting (HP:0000127) | 7.43162919 |
| 7 | Hyperaldosteronism (HP:0000859) | 7.30896102 |
| 8 | Abnormality of magnesium homeostasis (HP:0004921) | 7.23105760 |
| 9 | * Abnormal urine output (HP:0012590) | 7.19429651 |
| 10 | * Abnormality of renal excretion (HP:0011036) | 6.44397841 |
| 11 | Tetany (HP:0001281) | 6.37102233 |
| 12 | Alkalosis (HP:0001948) | 6.25878673 |
| 13 | Abnormality of renin-angiotensin system (HP:0000847) | 5.79181824 |
| 14 | Gout (HP:0001997) | 5.72696421 |
| 15 | * Polydipsia (HP:0001959) | 5.15680063 |
| 16 | * Abnormal drinking behavior (HP:0030082) | 5.15680063 |
| 17 | Hypokalemia (HP:0002900) | 5.06940549 |
| 18 | Increased purine levels (HP:0004368) | 4.29924946 |
| 19 | Hyperuricemia (HP:0002149) | 4.29924946 |
| 20 | Abnormality of potassium homeostasis (HP:0011042) | 4.05633023 |
| 21 | Hypercalciuria (HP:0002150) | 3.91290251 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.59128436 |
| 23 | Hyponatremia (HP:0002902) | 3.57177422 |
| 24 | Adrenal overactivity (HP:0002717) | 3.56190776 |
| 25 | Hyperglycinuria (HP:0003108) | 3.55165404 |
| 26 | Proximal tubulopathy (HP:0000114) | 3.53342746 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.38666317 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23974773 |
| 29 | * Abnormality of sodium homeostasis (HP:0010931) | 3.04984140 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.86806005 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 2.86806005 |
| 32 | Ketoacidosis (HP:0001993) | 2.85150150 |
| 33 | Renal tubular acidosis (HP:0001947) | 2.84317700 |
| 34 | Nephrocalcinosis (HP:0000121) | 2.83757888 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.64544645 |
| 36 | Chondrocalcinosis (HP:0000934) | 2.54403264 |
| 37 | Decreased circulating renin level (HP:0003351) | 2.52850919 |
| 38 | Ketosis (HP:0001946) | 2.42507006 |
| 39 | Abnormality of Sharpey fibers (HP:0100685) | 2.40153715 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36755415 |
| 41 | * Dehydration (HP:0001944) | 2.32346226 |
| 42 | Glycosuria (HP:0003076) | 2.31072501 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.31072501 |
| 44 | Hypotension (HP:0002615) | 2.21531950 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.20511668 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.20511668 |
| 47 | Tubulointerstitial fibrosis (HP:0005576) | 2.18718295 |
| 48 | Generalized muscle weakness (HP:0003324) | 2.17322785 |
| 49 | Metabolic alkalosis (HP:0200114) | 11.1920234 |
| 50 | Hypokalemic alkalosis (HP:0001949) | 10.4087848 |
| 51 | Hyperphosphaturia (HP:0003109) | 1.96570042 |
| 52 | Tubular atrophy (HP:0000092) | 1.95848667 |
| 53 | * Vomiting (HP:0002013) | 1.94717151 |
| 54 | Large eyes (HP:0001090) | 1.91891992 |
| 55 | Nephrolithiasis (HP:0000787) | 1.90704501 |
| 56 | Facial shape deformation (HP:0011334) | 1.87949742 |
| 57 | Potter facies (HP:0002009) | 1.87949742 |
| 58 | Hyperglycinemia (HP:0002154) | 1.87668872 |
| 59 | Abnormal urine phosphate concentration (HP:0012599) | 1.85013798 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81446268 |
| 61 | Hyperammonemia (HP:0001987) | 1.79879898 |
| 62 | Delayed CNS myelination (HP:0002188) | 1.79633898 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 1.76441543 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76441543 |
| 65 | Glomerulosclerosis (HP:0000096) | 1.73911503 |
| 66 | Delayed epiphyseal ossification (HP:0002663) | 1.71970399 |
| 67 | Metabolic acidosis (HP:0001942) | 1.67593664 |
| 68 | Renal tubular dysfunction (HP:0000124) | 1.67484633 |
| 69 | Hypophosphatemia (HP:0002148) | 1.64499021 |
| 70 | Enlarged kidneys (HP:0000105) | 1.61663008 |
| 71 | Impaired platelet aggregation (HP:0003540) | 1.59299891 |
| 72 | Abnormal platelet function (HP:0011869) | 1.59299891 |
| 73 | Focal segmental glomerulosclerosis (HP:0000097) | 1.58338827 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 1.57308508 |
| 75 | Rickets (HP:0002748) | 1.53605575 |
| 76 | Metaphyseal cupping (HP:0003021) | 1.51509599 |
| 77 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.50074746 |
| 78 | Lethargy (HP:0001254) | 1.48623936 |
| 79 | Widely patent fontanelles and sutures (HP:0004492) | 1.45827661 |
| 80 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.44440728 |
| 81 | Abnormality of the renal cortex (HP:0011035) | 1.43912850 |
| 82 | Abnormality of renal resorption (HP:0011038) | 1.42221833 |
| 83 | Confusion (HP:0001289) | 1.41654824 |
| 84 | Vascular calcification (HP:0004934) | 1.41636543 |
| 85 | Hyperkalemia (HP:0002153) | 1.41466581 |
| 86 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.39601966 |
| 87 | Malnutrition (HP:0004395) | 1.38861057 |
| 88 | Lymphangioma (HP:0100764) | 1.37597082 |
| 89 | Osteopenia (HP:0000938) | 1.37585901 |
| 90 | Methylmalonic aciduria (HP:0012120) | 1.36884949 |
| 91 | Tubulointerstitial abnormality (HP:0001969) | 1.35734674 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.33011743 |
| 93 | Paresthesia (HP:0003401) | 1.30182044 |
| 94 | Bicornuate uterus (HP:0000813) | 1.29648849 |
| 95 | Hypothermia (HP:0002045) | 1.27936091 |
| 96 | Cardiovascular calcification (HP:0011915) | 1.26491030 |
| 97 | Thin bony cortex (HP:0002753) | 1.26152728 |
| 98 | Acute encephalopathy (HP:0006846) | 1.24585135 |
| 99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.24414685 |
| 100 | Nausea (HP:0002018) | 1.22851649 |
| 101 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.20461763 |
| 102 | Premature birth (HP:0001622) | 1.19534204 |
| 103 | Tachypnea (HP:0002789) | 1.18464565 |
| 104 | Metaphyseal dysplasia (HP:0100255) | 1.18108231 |
| 105 | Abnormality of the renal medulla (HP:0100957) | 1.17311245 |
| 106 | Intellectual disability, moderate (HP:0002342) | 1.10173984 |
| 107 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.09758739 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.09137198 |
| 109 | Polyhydramnios (HP:0001561) | 1.07276837 |
| 110 | Small for gestational age (HP:0001518) | 1.04327160 |
| 111 | Abnormal tarsal ossification (HP:0008369) | 1.00705173 |
| 112 | Neonatal death (HP:0003811) | 0.99462132 |
| 113 | Thyroid-stimulating hormone excess (HP:0002925) | 0.95857672 |
| 114 | Persistence of primary teeth (HP:0006335) | 0.94302462 |
| 115 | Osteomalacia (HP:0002749) | 0.83430105 |
| 116 | Abnormality of the fingertips (HP:0001211) | 0.78226844 |
| 117 | Hyperphosphatemia (HP:0002905) | 0.76363725 |
| 118 | Hypophosphatemic rickets (HP:0004912) | 0.75803248 |
| 119 | Abnormality of macular pigmentation (HP:0008002) | 0.75199193 |
| 120 | Enlarged epiphyses (HP:0010580) | 0.73082589 |
| 121 | Esophageal varix (HP:0002040) | 0.68462045 |
| 122 | Abnormal foot bone ossification (HP:0010675) | 0.66767994 |
| 123 | Stage 5 chronic kidney disease (HP:0003774) | 0.65891196 |
| 124 | Amelogenesis imperfecta (HP:0000705) | 0.63520224 |
| 125 | Abnormality of carpal bone ossification (HP:0006257) | 0.63084579 |
| 126 | Choanal stenosis (HP:0000452) | 0.61497472 |
| 127 | Visceral angiomatosis (HP:0100761) | 0.60816252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 7.78282315 |
| 2 | WNK4 | 6.66227753 |
| 3 | STK39 | 2.68193844 |
| 4 | BCKDK | 2.31652564 |
| 5 | SGK494 | 2.07957666 |
| 6 | SGK223 | 2.07957666 |
| 7 | WNK3 | 11.8509273 |
| 8 | SGK2 | 1.79111136 |
| 9 | WNK1 | 1.69369137 |
| 10 | PDK4 | 1.62253478 |
| 11 | PDK3 | 1.62253478 |
| 12 | STK38L | 1.61248474 |
| 13 | SGK3 | 1.51631899 |
| 14 | NEK1 | 1.32235329 |
| 15 | PDK2 | 1.28346257 |
| 16 | MST4 | 0.88740761 |
| 17 | STK38 | 0.85283170 |
| 18 | MST1R | 0.84292943 |
| 19 | LRRK2 | 0.67903003 |
| 20 | TIE1 | 0.64265862 |
| 21 | SGK1 | 0.57024195 |
| 22 | PINK1 | 0.53436286 |
| 23 | EPHB1 | 0.51680962 |
| 24 | TGFBR2 | 0.51520891 |
| 25 | FGFR4 | 0.50601960 |
| 26 | ERN1 | 0.49851803 |
| 27 | PRKAA1 | 0.48068925 |
| 28 | GSK3A | 0.45084293 |
| 29 | TRIB3 | 0.42197234 |
| 30 | PAK4 | 0.40679720 |
| 31 | PTK6 | 0.40647567 |
| 32 | GRK6 | 0.37778664 |
| 33 | MAP3K3 | 0.36578805 |
| 34 | MAPK15 | 0.35621900 |
| 35 | PIK3CG | 0.34234233 |
| 36 | MAP3K7 | 0.32730997 |
| 37 | PTK2 | 0.32539778 |
| 38 | AKT3 | 0.30803722 |
| 39 | PDPK1 | 0.29336192 |
| 40 | STK10 | 0.26153659 |
| 41 | PAK3 | 0.25507103 |
| 42 | FER | 0.25443350 |
| 43 | PRKD2 | 0.24841176 |
| 44 | DYRK1B | 0.23351769 |
| 45 | ABL2 | 0.22687603 |
| 46 | MET | 0.22113371 |
| 47 | MYLK | 0.21043982 |
| 48 | PDK1 | 0.20909900 |
| 49 | PTK2B | 0.20164083 |
| 50 | PRKCD | 0.19459785 |
| 51 | PRKAA2 | 0.18620594 |
| 52 | NTRK1 | 0.18487515 |
| 53 | PRKCI | 0.18316226 |
| 54 | PRKCH | 0.17947890 |
| 55 | PKN2 | 0.17095528 |
| 56 | PRKCZ | 0.16870553 |
| 57 | MAP3K2 | 0.15948375 |
| 58 | PRPF4B | 0.15645411 |
| 59 | RIPK1 | 0.15512598 |
| 60 | MAPK11 | 0.13343854 |
| 61 | INSRR | 0.12769463 |
| 62 | PRKD3 | 0.11874802 |
| 63 | MINK1 | 0.11704308 |
| 64 | BMX | 0.10623550 |
| 65 | NLK | 0.09069246 |
| 66 | SCYL2 | 0.08144450 |
| 67 | JAK2 | 0.07541536 |
| 68 | PRKCA | 0.07434426 |
| 69 | AKT2 | 0.06835429 |
| 70 | MAP3K11 | 0.06205674 |
| 71 | MAP2K3 | 0.05197414 |
| 72 | PDGFRA | 0.05047892 |
| 73 | * PRKACA | 0.04554005 |
| 74 | SRC | 0.03996573 |
| 75 | EPHA3 | 0.03757977 |
| 76 | LATS1 | 0.03716790 |
| 77 | MTOR | 0.03530245 |
| 78 | EPHB2 | 0.03522822 |
| 79 | ROCK1 | 0.03201025 |
| 80 | NME1 | 0.03172534 |
| 81 | ERBB4 | 0.03163849 |
| 82 | MAPK12 | 0.02809831 |
| 83 | FRK | 0.02544530 |
| 84 | DMPK | 0.01892456 |
| 85 | FGFR3 | 0.01433441 |
| 86 | RET | 0.01377553 |
| 87 | IRAK2 | 0.01135075 |
| 88 | STK11 | 0.01104628 |
| 89 | CDC42BPA | 0.01086728 |
| 90 | DAPK2 | 0.00921974 |
| 91 | CSNK1A1L | 0.00812457 |
| 92 | * PRKACG | 0.00590005 |
| 93 | EPHA4 | 0.00459687 |
| 94 | INSR | 0.00309632 |
| 95 | MAPKAPK3 | 0.00216817 |
| 96 | TESK1 | 0.00215898 |
| 97 | STK3 | 0.00054010 |
| 98 | MARK2 | -0.0723750 |
| 99 | HIPK2 | -0.0716857 |
| 100 | RPS6KA2 | -0.0713940 |
| 101 | MAP2K2 | -0.0691336 |
| 102 | FGFR2 | -0.0665607 |
| 103 | MAP3K1 | -0.0663780 |
| 104 | CDK12 | -0.0646066 |
| 105 | ABL1 | -0.0623538 |
| 106 | NTRK3 | -0.0612499 |
| 107 | TAOK2 | -0.0593927 |
| 108 | * RPS6KA3 | -0.0580392 |
| 109 | PIK3CA | -0.0569187 |
| 110 | MAPK8 | -0.0560267 |
| 111 | PRKCE | -0.0554003 |
| 112 | MAPK10 | -0.0551272 |
| 113 | BCR | -0.0548911 |
| 114 | MAPK3 | -0.0547443 |
| 115 | * CSNK1A1 | -0.0534489 |
| 116 | ICK | -0.0482737 |
| 117 | TGFBR1 | -0.0480913 |
| 118 | PRKD1 | -0.0472809 |
| 119 | SIK1 | -0.0466068 |
| 120 | NEK9 | -0.0452141 |
| 121 | TRPM7 | -0.0437523 |
| 122 | DAPK1 | -0.0433879 |
| 123 | IGF1R | -0.0431204 |
| 124 | PRKCG | -0.0428958 |
| 125 | MAP3K12 | -0.0428141 |
| 126 | GRK1 | -0.0407536 |
| 127 | MAP2K6 | -0.0381419 |
| 128 | MELK | -0.0368638 |
| 129 | LATS2 | -0.0367738 |
| 130 | KSR1 | -0.0349304 |
| 131 | MAP2K1 | -0.0322189 |
| 132 | JAK1 | -0.0294957 |
| 133 | PIM1 | -0.0261318 |
| 134 | YES1 | -0.0260194 |
| 135 | CAMKK2 | -0.0212939 |
| 136 | MARK3 | -0.0209505 |
| 137 | BRSK2 | -0.0190587 |
| 138 | CDK5 | -0.0185084 |
| 139 | ROCK2 | -0.0141948 |
| 140 | CSK | -0.0106233 |
| 141 | PRKCQ | -0.0085535 |
| 142 | KSR2 | -0.0014008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.34649710 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.73292916 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.44959301 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.21364111 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.21276850 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.18556245 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.05820200 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.05310933 |
| 9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.93284102 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51635596 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36135285 |
| 12 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.31010108 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.29626542 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.22025107 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.14359253 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.12220457 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08606670 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.07191813 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02214460 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.96444986 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89546853 |
| 22 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.87559767 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76575657 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72651147 |
| 25 | Endometrial cancer_Homo sapiens_hsa05213 | 1.62910483 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62503407 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.54551544 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53616112 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49837414 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.48112827 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.40828574 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37063672 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35700014 |
| 34 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.34492750 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.33682776 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28404812 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26339533 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24794468 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18437170 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18242426 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.11298592 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.10041704 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09828272 |
| 44 | Melanoma_Homo sapiens_hsa05218 | 1.09731029 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00214747 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95662576 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93838953 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89141323 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87679104 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87426520 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85232173 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84404463 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84096201 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81256440 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80851866 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77143196 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 0.77121191 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76860754 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76337178 |
| 60 | Prostate cancer_Homo sapiens_hsa05215 | 0.76140271 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75083893 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74851383 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74028758 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73749731 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72826458 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72639587 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68451858 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64996385 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63417216 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.62702965 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60509272 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58775314 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57576362 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57154859 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56943806 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56890720 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56456677 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54296498 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52210235 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51113348 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.48534299 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47286944 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42798127 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40298528 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37943964 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37472736 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35374753 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33689133 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31266151 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30347738 |
| 91 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29972111 |
| 92 | * Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.29259262 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28937582 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25814021 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24420823 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.23774865 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22405862 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21936582 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21716514 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.21137193 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16622674 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15820201 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14874932 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14799417 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14741800 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.13911336 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.13246893 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.12088932 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.11981323 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10191610 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.08717038 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.08584856 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06458223 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.06415182 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05983877 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.05732598 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.05449339 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.05098483 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.04921535 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04656159 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.03911586 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.03751832 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03631503 |
| 124 | Salivary secretion_Homo sapiens_hsa04970 | 0.03335544 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02815404 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0414679 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0268696 |

